Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination dietary supplement containing a blend of **micronutrients** (11 vitamins and 6 minerals) and **docosahexaenoic acid (DHA)**, an omega-3 polyunsaturated fatty acid. The supplement is formulated to support cognitive function and healthy aging, designed specifically for populations at risk of nutritional deficiency, such as older adults. **Mechanisms of action** are attributed to the synergistic effects of micronutrient repletion (providing essential cofactors for cellular and neurological functions) and DHA, which is critical for neuronal membrane structure and function, as well as anti-inflammatory and antioxidant effects. The formulation is administered orally and often includes other ingredients such as phosphatidylserine. Current evidence suggests benefit in models of cognitive decline through enhancement of antioxidant defenses, reduction of neuroinflammation, and upregulation of neurotrophic factors[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on micronutrients + docosahexaenoic acid.